๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Determining Which Patients with Ductal Carcinoma In Situ Should Receive Tamoxifen

โœ Scribed by Warrick, Joshua; Allred, D. Craig


Book ID
121961875
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
53 KB
Volume
23
Category
Article
ISSN
1043-321X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Physician recommendations regarding tamo
โœ Tina W. F. Yen; Kelly K. Hunt; Nadeem Q. Mirza; Eva S. Thomas; S. Eva Singletary ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB

## Abstract ## BACKGROUND To date, the impact of the National Surgical Adjuvant Breast and Bowel Project (NSABP) Bโ€24 trial reported in 1999 on the use of tamoxifen after surgery for ductal carcinoma in situ (DCIS) is unknown. The current study was designed to evaluate the impact of NSABP Bโ€24 on